|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007131,
umls-concept:C0008838,
umls-concept:C0019029,
umls-concept:C0030705,
umls-concept:C0205187,
umls-concept:C0205420,
umls-concept:C0220901,
umls-concept:C0282460,
umls-concept:C0441771,
umls-concept:C0549193,
umls-concept:C0817096,
umls-concept:C1514811,
umls-concept:C1522449,
umls-concept:C1561577,
umls-concept:C1706462
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2005-2-8
|
|
pubmed:abstractText |
To evaluate the efficacy of concurrent radiochemotherapy in patients with stage III non-small cell lung cancer (NSCLC), and to examine the effect of hemoglobin levels on survival of those patients. The negative impact of anemia on survival has been noticed for other cancer sites including the head and neck, and the uterine cervix, but it has been rarely described in NSCLC cancer patients treated with radiotherapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0171-5216
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
131
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
261-9
|
|
pubmed:meshHeading |
pubmed-meshheading:15616830-Aged,
pubmed-meshheading:15616830-Aged, 80 and over,
pubmed-meshheading:15616830-Antineoplastic Agents,
pubmed-meshheading:15616830-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:15616830-Chemotherapy, Adjuvant,
pubmed-meshheading:15616830-Cisplatin,
pubmed-meshheading:15616830-Dose Fractionation,
pubmed-meshheading:15616830-Drug Administration Schedule,
pubmed-meshheading:15616830-Female,
pubmed-meshheading:15616830-Hemoglobins,
pubmed-meshheading:15616830-Humans,
pubmed-meshheading:15616830-Lung Neoplasms,
pubmed-meshheading:15616830-Male,
pubmed-meshheading:15616830-Middle Aged,
pubmed-meshheading:15616830-Neoplasm Staging,
pubmed-meshheading:15616830-Prognosis,
pubmed-meshheading:15616830-Radiation-Sensitizing Agents,
pubmed-meshheading:15616830-Radiotherapy, Adjuvant,
pubmed-meshheading:15616830-Treatment Outcome,
pubmed-meshheading:15616830-Tumor Markers, Biological
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Concurrent low-dose cisplatin and thoracic radiotherapy in patients with inoperable stage III non-small cell lung cancer: a phase II trial with special reference to the hemoglobin level as prognostic parameter.
|
|
pubmed:affiliation |
Department of Radiotherapy and Radiation Oncology, University of Göttingen, Robert Koch Strasse 40, 37075 Göttingen, Germany. opradie@gwdg.de
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Clinical Trial, Phase II
|
